Antipsychotic effects of caerulein on chronic schizophrenia
Moroharu, T.; Watanabe, N.; Ito, M.
Seishin Shinkeigaku Zasshi 85(9): 611-615
1983
ISSN/ISBN: 0033-2658 PMID: 6145173 Document Number: 207219
Document emailed within 1 workday
Related Documents
Moroji, T.; Matsushita, K. 1983: Antipsychotic action of ceruletide diethylamine (caerulein), a substance resembling CCK-8 Seishin Shinkeigaku Zasshi 85(11): 802-804Krzystanek, M.; Krysta, K.; Janas-Kozik, M.łg.; Martyniak, E.; Rybakowski, J. 2019: Risk Factors for Noncompliance with Antipsychotic Medication in Long-Term Treated Chronic Schizophrenia Patients Psychiatria Danubina 31(Suppl 3): 543-548
Eren, E.; Ayşenur Yeğin; Yilmaz, N.; Herken, H. 2010: Serum Total Homocystein, Folate and Vitamin B12 Levels and their Correlation with Antipsychotic Drug Doses in Adult Male Patients with Chronic Schizophrenia Clinical Laboratory 56(11-12): 513-518
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Hashimoto, K.; Iyo, M. 2002: Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs Nihon Shinkei Seishin Yakurigaku Zasshi 22(1): 3-13
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Jones, B.; Basson, B.R.; Walker, D.J.; Crawford, A.M.; Kinon, B.J. 2001: Weight change and atypical antipsychotic treatment in patients with schizophrenia Journal of Clinical Psychiatry 62(Suppl): 41-44
Roth, R.H.; Bacopoulos, N.G.; Bustos, G.; Redmond, D.E. 1980: Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates Advances in Biochemical Psychopharmacology 24: 513-520
Tsygankov, B.D.; Agasarain, E.G.; Zykova, A.S. 2014: Antipsychotic drugs and their influence on the carbohydrate metabolism in patients with schizophrenia-spectrum disorders Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(5): 86-91
Klushnik, T.P.; Syriachenko, T.M.; Brusov, O.S.; Sarmanova, Z.V.; Otman, I.N.; Dupin, A.M.; Sokolov, R.E. 2008: Serum immunological markers as predictors of effectiveness of antipsychotic therapy in patients with schizophrenia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(1): 31-35
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538
Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48
Yanaura, S.; Ishikawa, S. 1977: Effects of caerulein on the biliary system Nihon Heikatsukin Gakkai Zasshi 13(4): 284-286
Sudo, K.; Koyama, T.; Ichikawa, J.; Yasuda, M.; Kazawa, T. 1983: Changes in the eye movements of chronic schizophrenics as a result of treatment with a CCK-8-like drug (caerulein) Seishin Shinkeigaku Zasshi 85(11): 805-807
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914
Papp, M.; Varga, G.; Fodor, I.; Tóth, E.I.; Folly, G. 1984: Paradoxical effects of submaximal and supramaximal doses of caerulein on the pancreas Orvosi Hetilap 125(37): 2261-2263
Korb, F.A.; Trzebiatowska, I.; Janikova, E.; Winkler-Skaza, V.; Ilies, D.; Peciukaitiene, D.; Anders, M.; Simon, L.; Smulevich, A.B.; Dossenbach, M. 2003: The intercontinental schizophrenia outpatient health outcomes (ic-soho) study: baseline clinical and functional characteristics and antipsychotic use patterns in the central and eastern europe (cee) region Psychiatria Danubina 15(3-4): 163-174
Georgiev, A.; Probst, M.; De Hert, M.; Genova, V.; Tonkova, A.; Vancampfort, D. 2012: Acute effects of progressive muscle relaxation on state anxiety and subjective well-being in chronic Bulgarian patients with schizophrenia Psychiatria Danubina 24(4): 367-372
Suzuki, S. 1982: The mental maturation and verbal alteration in a mild case of chronic non-paranoiac schizophrenia. a linguistic-phenomenological approach to the concept of schizophrenia simplex Seishin Shinkeigaku Zasshi 84(1): 1-19